TITLE

Cardiovascular complications of cirrhosis

AUTHOR(S)
M&3x00F8;ller, S.; Henriksen, J. H.
PUB. DATE
February 2008
SOURCE
Gut;Feb2008, Vol. 57 Issue 2, p268
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Cardiovascular complications of cirrhosis include cardiac dysfunction and abnormalities in the central, splanchnic and peripheral circulation, and haemodynamic changes caused by humoral and nervous dysregulation. Cirrhotic cardiomyopathy implies systolic and diastolic dysfunction and electrophysiological abnormalities, an entity that is different from alcoholic heart muscle disease. Being clinically latent, cirrhotic cardiomyopathy can be unmasked by physical or pharmacological strain. Consequently, caution should be exercised in the case of stressful procedures, such as large volume paracentesis without adequate plasma volume expansion, transjugular intrahepatic portosystemic shunt (TIPS) insertion, peritoneovenous shunting and surgery. Cardiac failure is an important cause of mortality after liver transplantation, but improved liver function has also been shown to reverse the cardiac abnormalities. No specific treatment can be recommended, and cardiac failure should be treated as in non-cirrhotic patients with sodium restriction, diuretics, and oxygen therapy when necessary. Special care should be taken with the use of ACE inhibitors and angiotensin antagonists in these patients. The clinical significance of cardiovascular complications and cirrhotic cardiomyopathy is an important topic for future research, and the initiation of new randomised studies of potential treatments for these complications is needed.
ACCESSION #
28843126

 

Related Articles

  • Chronic heart failure: pathophysiology, diagnosis and treatment. Nicholson, Christopher // Nursing Older People;Sep2014, Vol. 26 Issue 7, p29 

    Heart failure has significant prevalence in older people: the mean average age of patients with the condition is 77. It has serious prognostic and quality of life implications for patients, as well as health service costs. Diagnosis requires confirmatory investigations and consideration of...

  • Newer drug therapies in heart failure.  // Practice Nurse;10/12/2012, Vol. 42 Issue 15, p38 

    The article discusses the use of alternative or new therapies in left ventricular systolic dysfunction. Both angiotensin converting enzyme inhibitor and beta blockers are considered first line drug therapies for heart failure. Side effects associated with beta blockers are bronchoconstriction,...

  • Cardiovascular complications of cirrhosis. S Møller // Postgraduate Medical Journal;Jan2009, Vol. 85 Issue 999, p44 

    Cardiovascular complications of cirrhosis include cardiac dysfunction and abnormalities in the central, splanchnic and peripheral circulation, and haemodynamic changes caused by humoral and nervous dysregulation. Cirrhotic cardiomyopathy implies systolic and diastolic dysfunction and...

  • Effects of antihypertensive treatment on cardiovascular autonomic control: a prospective study. Kiselev, Anton R.; Gridnev, Vladimir I.; Prokhorov, Mikhail D.; Karavaev, Anatoly S.; Posnenkova, Olga M.; Ponomarenko, Vladimir I.; Bezruchko, Boris P. // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;Dec2014, Vol. 14 Issue 8, p701 

    Objective: The aim of study was to propose an approach to the control of dynamics of autonomic dysfunction in cardiovascular system (CVS) under antihypertensive treatment (AT) in patients with arterial hypertension (AH), based on individual features of synchronization of 0.1-Hz rhythms in heart...

  • Aspirin and ACE Inhibitors in Congestive Heart Failure. Miller, Karl E. // American Family Physician;5/1/2004, Vol. 69 Issue 9, p2214 

    Deals with a study conducted on the effect of aspirin and angiotensin-converting enzyme inhibitors on the treatment of congestive heart failure. Echocardiography and cardiopulmonary exercise testing conducted to patients; Survival rates of patients with ischemic or nonischemic cardiomyopathy;...

  • Preventing heart failure.  // Mayo Clinic Health Letter;Jun2011, Vol. 29 Issue 6, p1 

    The article focuses on the recognition and management of the risk factors involved in the development of heart failure. The author discusses the conditions that trigger the occurrence of heart failure such as coronary artery disease, faulty heart valves and heart muscle damage. Particular focus...

  • ACE INHIBITORS AND ARBS FOR RENAL DISEASE. FARMAND, NEGEEN; SHARMA, ATUL; O¿Connell, Claire Babcock // Clinical Advisor;Jul2011, Vol. 14 Issue 7, p71 

    The article provides an answer to a question if angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs) protect diabetic patients from renal disease.

  • Molecular Targets of Antihypertensive Peptides: Understanding the Mechanisms of Action Based on the Pathophysiology of Hypertension. Majumder, Kaustav; Wu, Jianping // International Journal of Molecular Sciences;2015, Vol. 16 Issue 1, p256 

    There is growing interest in using functional foods or nutraceuticals for the prevention and treatment of hypertension or high blood pressure. Although numerous preventive and therapeutic pharmacological interventions are available on the market, unfortunately, many patients still suffer from...

  • Journal scan.  // Nursing Older People;Sep2014, Vol. 26 Issue 7, p13 

    The article presents on abstract on topics related to nursing older people including studies on the treatment for post-herpetic neuralgia, the efficacy of therapy after stroke, and ways to impart bad news to patients.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics